Exchange Traded Concepts, LLC Myriad Genetics Inc Transaction History

Exchange Traded Concepts, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$14.51 - $20.99 $30,703 - $44,414	2,116 Added 42.7%	7,072 $103,000
Q3 2022 Oct 07, 2022	BUY	$18.21 - $27.88 $24,911 - $38,139	1,368 Added 38.13%	4,956 $95,000
Q2 2022 Jul 20, 2022	BUY	$16.45 - $25.88 $40,384 - $63,535	2,455 Added 216.68%	3,588 $65,000
Q1 2022 Apr 26, 2022	BUY	$22.67 - $28.01 $25,685 - $31,735	1,133 New	1,133 $29,000
Q1 2020 Apr 14, 2020	SELL	$9.78 - $29.53 $30,542 - $92,222	-3,123 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$20.93 - $35.1 $65,364 - $109,617	3,123 New	3,123 $85,000

230

88.9M

43.5K

18.1K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.